PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Bakuchiol showed beneficial results comparable to topical retinoids [PMID:36176207]
Corylin and seed polysaccharides demonstrate anti-osteoporotic effects [PMID:41257975, PMID:40403806]
Seed extract attenuated dexamethasone-induced muscle atrophy in mice [PMID:35728709]
Bakuchiol and psoralidin demonstrate cytotoxic and antitumor potential against various cancer cell lines [PMID:36717993, PMID:11440079]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36176207 (2022) — Applications of bakuchiol in dermatology: Systematic review of the literature. · Journal of cosmetic dermatology
- 2.PMID: 22228944 (2010) — Psoralea corylifolia Linn.-"Kushtanashini". · Pharmacognosy reviews
- 3.PMID: 22772918 (2012) — Isobavachalcone: an overview. · Chinese journal of integrative medicine
- 4.PMID: 40893669 (2025) — High-efficient discovering the potent anti-Notum agents from herbal medicines for combating glucocorticoid-induced osteoporosis. · Acta pharmaceutica Sinica. B
- 5.PMID: 36717993 (2023) — Bakuchiol: A Potential Anticancer Compound from Psoralea corylifolia Linn.